FDA Approved: RABEPRAZOLE SODIUM — Original Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved the original application for rabeprazole sodium from Lannett Company, Inc., enabling a generic version of the proton pump inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Rabeprazole sodium (rabeprazole)

Snippet

ORIG AP for RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM)